×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Targeting Hope for Oncology Patients: Perceptions and Considerations for Genetic Testing and Precision Medicine
Session Chair(s)
Wesley D Peters, MS
Research Specialist III, Patient Experience
Evidera/ Thermo Fisher Scientific, United States
This session provides new thinking and examples of how to design and implement qualitative research around genetic testing and precision medicine for oncology patients.
Learning Objective : Discuss approaches to designing, executing, and analyzing qualitative research around patient perceptions of genetic testing and precision medicine; Discuss unmet needs around patient education and the integration of genetic counselor into care team; Examine the application of a behavioral framework to understand decision to get a genetic testing for oncology patients.
Speaker(s)
Measuring Value in Oncology: Are we Keeping Pace with Science?
Solange Corriol-Rohou, DrMed, MD, PhD
AstraZeneca , France
Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
Targeting Hope for Oncology Patients: Perceptions and Considerations for Genetic Testing and Precision Medicine
Jennifer Malinowski, PhD, MS
Johnson & Johnson Innovative Medicine, United States
Director, Access and Policy Research
Have an account?